Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting
FH Messerli, MR Weir, JM Neutel - American journal of …, 2002 - academic.oup.com
Background: Community-based studies are conducted to determine the degree to which
therapeutic interventions will succeed in real world settings. This large practice-based …
therapeutic interventions will succeed in real world settings. This large practice-based …
Triple-drug, fixed-dose combinations for the treatment of hypertension: focus on olmesartan/amlodipine/hydrochlorothiazide combination.
SG Chrysant - Drugs of Today (Barcelona, Spain: 1998), 2011 - europepmc.org
Hypertension is a major risk factor for cardiovascular, renal and stroke complications. Its
incidence continues to rise worldwide, and it is projected that by the year 2025, 1 billion …
incidence continues to rise worldwide, and it is projected that by the year 2025, 1 billion …
[HTML][HTML] Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized …
Background Hypertension and dyslipidemia significantly contribute to cardiovascular
disease development. Their coexistence poses challenges in managing multiple …
disease development. Their coexistence poses challenges in managing multiple …
Fixed-dose combination therapy in hypertension: focus on fixed-dose combination of amlodipine and valsartan (Exforge®)
S Aslam - Clinical Medicine. Therapeutics, 2009 - journals.sagepub.com
Hypertension is the leading cause of disability and cardiovascular mortality world-wide.
Approximately one-third of the US adult population and over a billion people world-wide …
Approximately one-third of the US adult population and over a billion people world-wide …
Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who …
SM Kang, JC Youn, SC Chae, CG Park, JY Yang… - Clinical …, 2011 - Elsevier
BACKGROUND: The number of hypertensive patients achieving treatment targets is not
ideal with therapies that engage a single mechanism of action, and combination therapies …
ideal with therapies that engage a single mechanism of action, and combination therapies …
[HTML][HTML] Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study
R Koyanagi, N Hagiwara, J Yamaguchi… - Journal of …, 2013 - Elsevier
Background The effects of the combination of angiotensin II receptor blocker (ARB) plus
dihydropyridine calcium channel blockers (DHP-CCBs), which is known as a potent …
dihydropyridine calcium channel blockers (DHP-CCBs), which is known as a potent …
Analysis of secondary care data to evaluate the clinical relevance of the drug-drug interaction between amlodipine and simvastatin
S Fuhrmann, A Koppen, A Seeling, H Knoth… - Zeitschrift für Evidenz …, 2019 - Elsevier
Background Pharmacokinetic analyses revealed an increase in the bioavailability of
simvastatin when co-administered with amlodipine [Nishio S et al. Hypertensin research …
simvastatin when co-administered with amlodipine [Nishio S et al. Hypertensin research …
Atorvastatin therapy under clinical practice conditions-which LDL-C levels are achieved in patients at very high cardiovascular risk?
U Laufs, C Jannowitz, D Pittrow - … Medizinische Wochenschrift (1946 …, 2017 - europepmc.org
Current information on the utilisation of atorvastatin under clinical practice conditions is
limited. The cross sectional study DISCOVER documented in the period from June until …
limited. The cross sectional study DISCOVER documented in the period from June until …
Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension
JE Frampton, LJ Scott - American journal of cardiovascular drugs, 2009 - Springer
Single-pill combinations of the dihydropyridine calcium channel blocker (CCB) amlodipine
and the angiotensin II receptor blocker valsartan (amlodipine/valsartan)[Exforge®] are …
and the angiotensin II receptor blocker valsartan (amlodipine/valsartan)[Exforge®] are …
Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus …
N Braun, HJ Ulmer, A Ansari, R Handrock… - … medical research and …, 2009 - Taylor & Francis
Background and objective: For patients with moderate hypertension (grade 2, defined as
systolic blood pressure [SBP] 160–179 mmHg and/or diastolic blood pressure [DBP] 100 …
systolic blood pressure [SBP] 160–179 mmHg and/or diastolic blood pressure [DBP] 100 …